Company news
Insmed Incorporated (NASDAQ:INSM) news
Insmed Incorporated news releases on 6ix. Latest, May 8, 2025: Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update
Press releases — page 2
Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update
May 7, 2025
Insmed To Present at the BofA Securities 2025 Health Care Conference
April 28, 2025
Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028
April 23, 2025
New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
April 22, 2025
Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025
April 22, 2025
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
March 24, 2025
Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
February 23, 2025
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
February 19, 2025
Insmed To Present at March 2025 Investor Conferences
February 10, 2025
Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
February 9, 2025
FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
February 5, 2025
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 1, 2025
Insmed To Present at December 2024 Investor Conferences
December 1, 2024
Insmed To Present at November 2024 Investor Conferences
November 5, 2024
Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
October 30, 2024
Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
October 23, 2024
Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
October 22, 2024
Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
October 16, 2024
New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
October 7, 2024
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
August 7, 2024
Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
July 28, 2024
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
July 2, 2024
Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
June 26, 2024
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 4, 2024
Insmed to Host Commercial Webinar on June 4, 2024
May 29, 2024
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
May 29, 2024
Insmed Announces Proposed $500 Million Public Offering of Common Stock
May 27, 2024
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
May 27, 2024
Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
May 26, 2024
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International C...
May 19, 2024
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
May 8, 2024
Insmed To Present at the BofA Securities Health Care Conference 2024
May 6, 2024
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
April 24, 2024
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
March 26, 2024
Insmed To Present at Three March Conferences
February 28, 2024
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
February 27, 2024
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
February 21, 2024
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
February 7, 2024
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
January 4, 2024
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 1, 2024
Insmed To Present at the Nasdaq 49th Investor Conference
November 28, 2023
Insmed To Present at Two November Conferences
November 7, 2023
Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe
November 1, 2023
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
October 25, 2023
Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List
October 25, 2023
Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI
October 23, 2023
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023
October 11, 2023
Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference
September 25, 2023
Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 5, 2023